Published in PLoS One on December 03, 2009
Genetic correction and analysis of induced pluripotent stem cells from a patient with gyrate atrophy. Proc Natl Acad Sci U S A (2011) 2.41
iPS cell modeling of Best disease: insights into the pathophysiology of an inherited macular degeneration. Hum Mol Genet (2012) 1.59
Consequences of oxidative stress in age-related macular degeneration. Mol Aspects Med (2012) 1.59
Stem cells in retinal regeneration: past, present and future. Development (2013) 1.59
Blood-derived human iPS cells generate optic vesicle-like structures with the capacity to form retinal laminae and develop synapses. Invest Ophthalmol Vis Sci (2012) 1.50
Specification of neuronal and glial subtypes from human pluripotent stem cells. Cell Mol Life Sci (2011) 1.40
The new paradigm: retinal pigment epithelium cells generated from embryonic or induced pluripotent stem cells. Pigment Cell Melanoma Res (2010) 1.32
Use of a synthetic xeno-free culture substrate for induced pluripotent stem cell induction and retinal differentiation. Stem Cells Transl Med (2012) 1.27
Rapid and efficient directed differentiation of human pluripotent stem cells into retinal pigmented epithelium. Stem Cells Transl Med (2013) 1.27
Toward the defined and xeno-free differentiation of functional human pluripotent stem cell-derived retinal pigment epithelial cells. Mol Vis (2011) 1.25
Long-term safety and efficacy of human-induced pluripotent stem cell (iPS) grafts in a preclinical model of retinitis pigmentosa. Mol Med (2012) 1.24
Highly sensitive in vitro methods for detection of residual undifferentiated cells in retinal pigment epithelial cells derived from human iPS cells. PLoS One (2012) 1.24
What is the point of large-scale collections of human induced pluripotent stem cells? Nat Biotechnol (2013) 1.20
Polarized secretion of PEDF from human embryonic stem cell-derived RPE promotes retinal progenitor cell survival. Invest Ophthalmol Vis Sci (2011) 1.18
Generation of retinal pigment epithelial cells from small molecules and OCT4 reprogrammed human induced pluripotent stem cells. Stem Cells Transl Med (2012) 1.11
Human RPE stem cells grown into polarized RPE monolayers on a polyester matrix are maintained after grafting into rabbit subretinal space. Stem Cell Reports (2014) 1.11
A simple and scalable process for the differentiation of retinal pigment epithelium from human pluripotent stem cells. Stem Cells Transl Med (2013) 1.09
Retinal repair with induced pluripotent stem cells. Transl Res (2013) 1.09
Concise Review: Patient-Specific Stem Cells to Interrogate Inherited Eye Disease. Stem Cells Transl Med (2015) 1.08
Functional analysis of serially expanded human iPS cell-derived RPE cultures. Invest Ophthalmol Vis Sci (2013) 1.07
Stem cell therapy for retinal diseases: update. Stem Cell Res Ther (2011) 1.05
Developing rods transplanted into the degenerating retina of Crx-knockout mice exhibit neural activity similar to native photoreceptors. Stem Cells (2013) 1.03
Developing cellular therapies for retinal degenerative diseases. Invest Ophthalmol Vis Sci (2014) 1.03
Identification and Correction of Mechanisms Underlying Inherited Blindness in Human iPSC-Derived Optic Cups. Cell Stem Cell (2016) 1.01
Stem cell-based therapeutic applications in retinal degenerative diseases. Stem Cell Rev (2011) 1.01
Cell replacement and visual restoration by retinal sheet transplants. Prog Retin Eye Res (2012) 1.01
Using human induced pluripotent stem cells to treat retinal disease. Prog Retin Eye Res (2013) 1.00
Translating induced pluripotent stem cells from bench to bedside: application to retinal diseases. Curr Gene Ther (2013) 1.00
Stem cell treatment of degenerative eye disease. Stem Cell Res (2015) 0.99
Induced pluripotent stem cells as custom therapeutics for retinal repair: progress and rationale. Exp Eye Res (2014) 0.97
Understanding photoreceptor outer segment phagocytosis: use and utility of RPE cells in culture. Exp Eye Res (2014) 0.96
Direct conversion of human fibroblasts into retinal pigment epithelium-like cells by defined factors. Protein Cell (2014) 0.96
Autosomal recessive retinitis pigmentosa due to ABCA4 mutations: clinical, pathologic, and molecular characterization. Invest Ophthalmol Vis Sci (2012) 0.94
Using flow cytometry to compare the dynamics of photoreceptor outer segment phagocytosis in iPS-derived RPE cells. Invest Ophthalmol Vis Sci (2012) 0.94
Stem cells as a therapeutic tool for the blind: biology and future prospects. Proc Biol Sci (2011) 0.93
Induced pluripotent stem cell therapies for geographic atrophy of age-related macular degeneration. Semin Ophthalmol (2011) 0.92
Translational read-through of the RP2 Arg120stop mutation in patient iPSC-derived retinal pigment epithelium cells. Hum Mol Genet (2014) 0.92
Stemming vision loss with stem cells. J Clin Invest (2010) 0.91
Retinal pigmented epithelial cells obtained from human induced pluripotent stem cells possess functional visual cycle enzymes in vitro and in vivo. J Biol Chem (2013) 0.91
Defined culture of human embryonic stem cells and xeno-free derivation of retinal pigmented epithelial cells on a novel, synthetic substrate. Stem Cells Transl Med (2015) 0.90
Structure and barrier properties of human embryonic stem cell-derived retinal pigment epithelial cells are affected by extracellular matrix protein coating. Tissue Eng Part A (2014) 0.90
Plasma membrane protein polarity and trafficking in RPE cells: past, present and future. Exp Eye Res (2014) 0.89
Advancing therapeutic strategies for inherited retinal degeneration: recommendations from the Monaciano Symposium. Invest Ophthalmol Vis Sci (2015) 0.88
Stem cells for retinal replacement therapy. Neurotherapeutics (2011) 0.88
Stem cell therapies for age-related macular degeneration: the past, present, and future. Clin Interv Aging (2015) 0.87
Retinoid uptake, processing, and secretion in human iPS-RPE support the visual cycle. Invest Ophthalmol Vis Sci (2014) 0.86
Optimization of Storage Temperature for Cultured ARPE-19 Cells. J Ophthalmol (2013) 0.86
Micro- and nanofluidic technologies for epigenetic profiling. Biomicrofluidics (2013) 0.85
Enhanced retinal pigment epithelium regeneration after injury in MRL/MpJ mice. Exp Eye Res (2011) 0.85
Stem cell-based therapies for age-related macular degeneration: current status and prospects. Int J Clin Exp Med (2014) 0.85
Profiling the microRNA Expression in Human iPS and iPS-derived Retinal Pigment Epithelium. Cancer Inform (2014) 0.84
Promises of stem cell therapy for retinal degenerative diseases. Graefes Arch Clin Exp Ophthalmol (2011) 0.84
Enhancing RPE Cell-Based Therapy Outcomes for AMD: The Role of Bruch's Membrane. Transl Vis Sci Technol (2014) 0.83
Regenerating Retinal Pigment Epithelial Cells to Cure Blindness: A Road Towards Personalized Artificial Tissue. Curr Stem Cell Rep (2015) 0.83
Potential of Induced Pluripotent Stem Cells (iPSCs) for Treating Age-Related Macular Degeneration (AMD). Cells (2016) 0.83
Prospectives for gene therapy of retinal degenerations. Curr Genomics (2012) 0.83
Stem cells: a new paradigm for disease modeling and developing therapies for age-related macular degeneration. J Transl Med (2013) 0.83
Generation of highly enriched populations of optic vesicle-like retinal cells from human pluripotent stem cells. Curr Protoc Stem Cell Biol (2015) 0.83
Transplantation of rat embryonic stem cell-derived retinal progenitor cells preserves the retinal structure and function in rat retinal degeneration. Stem Cell Res Ther (2015) 0.83
Current therapeutic developments in atrophic age-related macular degeneration. Br J Ophthalmol (2015) 0.83
Gene correction in patient-specific iPSCs for therapy development and disease modeling. Hum Genet (2016) 0.83
Engrafted human induced pluripotent stem cell-derived anterior specified neural progenitors protect the rat crushed optic nerve. PLoS One (2013) 0.82
Retinal pigment epithelium transplantation: concepts, challenges, and future prospects. Eye (Lond) (2015) 0.82
Efficient derivation of retinal pigment epithelium cells from stem cells. J Vis Exp (2015) 0.82
Cellular models and therapies for age-related macular degeneration. Dis Model Mech (2015) 0.82
Engineering a blood-retinal barrier with human embryonic stem cell-derived retinal pigment epithelium: transcriptome and functional analysis. Stem Cells Transl Med (2013) 0.81
Regenerative therapy for retinal disorders. J Ophthalmic Vis Res (2010) 0.81
Stem cell therapy for glaucoma: possibilities and practicalities. Expert Rev Ophthalmol (2011) 0.81
iPS Cells for Modelling and Treatment of Retinal Diseases. J Clin Med (2014) 0.81
Induced Pluripotent Stem Cell Therapies for Degenerative Disease of the Outer Retina: Disease Modeling and Cell Replacement. J Ocul Pharmacol Ther (2016) 0.81
Using Stem Cells to Model Diseases of the Outer Retina. Comput Struct Biotechnol J (2015) 0.81
Update on Clinical Trials in Dry Age-related Macular Degeneration. Middle East Afr J Ophthalmol (2016) 0.80
Prospects for clinical use of reprogrammed cells for autologous treatment of macular degeneration. Fibrogenesis Tissue Repair (2015) 0.80
eyeGENE(R): a novel approach to combine clinical testing and researching genetic ocular disease. Curr Opin Ophthalmol (2012) 0.80
Ultrathin Polyimide Membrane as Cell Carrier for Subretinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigment Epithelium. PLoS One (2015) 0.79
Recent Advances towards the Clinical Application of Stem Cells for Retinal Regeneration. Cells (2012) 0.79
A gene expression profile of the developing human retinal pigment epithelium. Mol Vis (2012) 0.79
RPE and neuronal differentiation of allotransplantated porcine ciliary epithelium-derived cells. Mol Vis (2011) 0.79
Robust Differentiation of mRNA-Reprogrammed Human Induced Pluripotent Stem Cells Toward a Retinal Lineage. Stem Cells Transl Med (2016) 0.79
Survival and migration of pre-induced adult human peripheral blood mononuclear cells in retinal degeneration slow (rds) mice three months after subretinal transplantation. Curr Stem Cell Res Ther (2014) 0.79
Large-scale purification of porcine or bovine photoreceptor outer segments for phagocytosis assays on retinal pigment epithelial cells. J Vis Exp (2014) 0.79
Efficient delivery and functional expression of transfected modified mRNA in human embryonic stem cell-derived retinal pigmented epithelial cells. J Biol Chem (2015) 0.79
The 3R principle: advancing clinical application of human pluripotent stem cells. Stem Cell Res Ther (2013) 0.79
Performing subretinal injections in rodents to deliver retinal pigment epithelium cells in suspension. J Vis Exp (2015) 0.78
Human iPSC derived disease model of MERTK-associated retinitis pigmentosa. Sci Rep (2015) 0.78
iPSC-Derived Retinal Pigment Epithelium Allografts Do Not Elicit Detrimental Effects in Rats: A Follow-Up Study. Stem Cells Int (2016) 0.78
Human Pluripotent Stem Cell-Derived Retinal Ganglion Cells: Applications for the Study and Treatment of Optic Neuropathies. Curr Ophthalmol Rep (2015) 0.78
Neural Stem Cells Derived by Small Molecules Preserve Vision. Transl Vis Sci Technol (2013) 0.78
Allogenic iPSC-derived RPE cell transplants induce immune response in pigs: a pilot study. Sci Rep (2015) 0.78
Generating retinal neurons by reprogramming retinal pigment epithelial cells. Expert Opin Biol Ther (2010) 0.78
Dry age-related macular degeneration: A currently unmet clinical need. Intractable Rare Dis Res (2012) 0.78
Transplantation of IL-10-transfected endothelial progenitor cells improves retinal vascular repair via suppressing inflammation in diabetic rats. Graefes Arch Clin Exp Ophthalmol (2016) 0.77
MicroRNA expression profiles of human iPS cells, retinal pigment epithelium derived from iPS, and fetal retinal pigment epithelium. J Vis Exp (2014) 0.77
Chapter 4 - Restoring Vision to the Blind: Stem Cells and Transplantation. Transl Vis Sci Technol (2014) 0.77
Induced Pluripotent Stem Cells: Development in the Ophthalmologic Field. Stem Cells Int (2016) 0.77
Comparative study of human embryonic stem cells (hESC) and human induced pluripotent stem cells (hiPSC) as a treatment for retinal dystrophies. Mol Ther Methods Clin Dev (2016) 0.77
Mislocalisation of BEST1 in iPSC-derived retinal pigment epithelial cells from a family with autosomal dominant vitreoretinochoroidopathy (ADVIRC). Sci Rep (2016) 0.76
Induced pluripotent stem cells without c-Myc ameliorate retinal oxidative damage via paracrine effects and reduced oxidative stress in rats. J Ocul Pharmacol Ther (2014) 0.76
Patient-Specific iPSC-Derived RPE for Modeling of Retinal Diseases. J Clin Med (2015) 0.76
Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell (2006) 120.51
Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell (2007) 101.42
Induced pluripotent stem cell lines derived from human somatic cells. Science (2007) 71.50
Human induced pluripotent stem cells free of vector and transgene sequences. Science (2009) 17.16
Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science (2007) 12.41
piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature (2009) 11.27
Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nat Biotechnol (2008) 10.29
Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature (2009) 9.29
The retinal pigment epithelium in visual function. Physiol Rev (2005) 8.59
Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds. Cell Stem Cell (2008) 7.79
Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. Proc Natl Acad Sci U S A (2008) 7.52
Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ Res (2009) 7.09
Generation of induced pluripotent stem cells from human blood. Blood (2009) 4.92
Toward the generation of rod and cone photoreceptors from mouse, monkey and human embryonic stem cells. Nat Biotechnol (2008) 4.50
Mutation of the receptor tyrosine kinase gene Mertk in the retinal dystrophic RCS rat. Hum Mol Genet (2000) 4.42
Inherited retinal dystrophy in the rat. J Cell Biol (1962) 3.60
Modeling early retinal development with human embryonic and induced pluripotent stem cells. Proc Natl Acad Sci U S A (2009) 3.53
Highly efficient differentiation of human ES cells and iPS cells into mature pancreatic insulin-producing cells. Cell Res (2009) 3.44
Peripherin. A rim-specific membrane protein of rod outer segment discs. Invest Ophthalmol Vis Sci (1987) 3.14
Directed differentiation of human embryonic stem cells into functional retinal pigment epithelium cells. Cell Stem Cell (2009) 3.09
Confluent monolayers of cultured human fetal retinal pigment epithelium exhibit morphology and physiology of native tissue. Invest Ophthalmol Vis Sci (2006) 2.74
Activated microglia in human retinitis pigmentosa, late-onset retinal degeneration, and age-related macular degeneration. Exp Eye Res (2003) 2.73
Derivation of functional retinal pigmented epithelium from induced pluripotent stem cells. Stem Cells (2009) 2.70
Photoreceptor degeneration in inherited retinal dystrophy delayed by basic fibroblast growth factor. Nature (1990) 2.61
Long-term safety and function of RPE from human embryonic stem cells in preclinical models of macular degeneration. Stem Cells (2009) 2.56
Characterization of the expression of MHC proteins in human embryonic stem cells. Proc Natl Acad Sci U S A (2002) 2.53
The role of the pigment epithelium in the etiology of inherited retinal dystrophy in the rat. J Cell Biol (1971) 2.51
Derivation and comparative assessment of retinal pigment epithelium from human embryonic stem cells using transcriptomics. Cloning Stem Cells (2004) 2.32
Generation of human-induced pluripotent stem cells in the absence of exogenous Sox2. Stem Cells (2009) 2.29
Human embryonic stem cells and their differentiated derivatives are less susceptible to immune rejection than adult cells. Stem Cells (2005) 2.24
Human embryonic stem cell-derived cells rescue visual function in dystrophic RCS rats. Cloning Stem Cells (2006) 2.23
Elucidating the phenomenon of HESC-derived RPE: anatomy of cell genesis, expansion and retinal transplantation. Exp Neurol (2008) 2.03
Phenotypic correction of murine hemophilia A using an iPS cell-based therapy. Proc Natl Acad Sci U S A (2009) 2.02
The drusenlike phenotype in aging Ccl2-knockout mice is caused by an accelerated accumulation of swollen autofluorescent subretinal macrophages. Invest Ophthalmol Vis Sci (2009) 1.84
Human embryonic stem cells possess immune-privileged properties. Stem Cells (2004) 1.82
Adult retinal pigment epithelial transplantation in exudative age-related macular degeneration. Am J Ophthalmol (2007) 1.82
RPE transplantation and its role in retinal disease. Prog Retin Eye Res (2007) 1.63
Retinal separation, retinotomy, and macular relocation: II. A surgical approach for age-related macular degeneration? Graefes Arch Clin Exp Ophthalmol (1993) 1.63
Expression, secretion, and age-related downregulation of pigment epithelium-derived factor, a serpin with neurotrophic activity. J Neurosci (1995) 1.55
Subretinal transplantation of bone marrow mesenchymal stem cells delays retinal degeneration in the RCS rat model of retinal degeneration. Exp Eye Res (2007) 1.48
Autologous transplantation of the retinal pigment epithelium and choroid in the treatment of neovascular age-related macular degeneration. Ophthalmology (2007) 1.44
Autologous translocation of the choroid and retinal pigment epithelium in age-related macular degeneration. Am J Ophthalmol (2006) 1.36
Transdifferentiation of retinal pigment epithelial cells from epithelial to mesenchymal phenotype. Invest Ophthalmol Vis Sci (1995) 1.36
Molecular characterization and functional analysis of phagocytosis by human embryonic stem cell-derived RPE cells using a novel human retinal assay. Mol Vis (2009) 1.35
Long-term preservation of cortically dependent visual function in RCS rats by transplantation. Nat Neurosci (2002) 1.31
Pigment epithelium-derived factor supports normal development of photoreceptor neurons and opsin expression after retinal pigment epithelium removal. J Neurosci (2000) 1.31
In vivo protection of photoreceptors from light damage by pigment epithelium-derived factor. Invest Ophthalmol Vis Sci (2001) 1.26
Long-term vision rescue by human neural progenitors in a rat model of photoreceptor degeneration. Invest Ophthalmol Vis Sci (2008) 1.22
Macular translocation with 360 degrees retinotomy for exudative age-related macular degeneration. Arch Ophthalmol (2002) 1.18
Ganglion cell loss in RCS rat retina: a result of compression of axons by contracting intraretinal vessels linked to the pigment epithelium. J Comp Neurol (1998) 1.17
Pigment epithelium-derived factor protects retinal ganglion cells. BMC Neurosci (2007) 1.17
Cell transplantation strategies for retinal repair. Prog Brain Res (2009) 1.14
Basic fibroblast growth factor is synthesized in cultured retinal pigment epithelial cells. Biochem Biophys Res Commun (1987) 1.07
Congenic strains of RCS rats with inherited retinal dystrophy. J Hered (1975) 1.07
Subretinal transplantation of forebrain progenitor cells in nonhuman primates: survival and intact retinal function. Invest Ophthalmol Vis Sci (2009) 1.04
Morphological changes in the Royal College of Surgeons rat retina during photoreceptor degeneration and after cell-based therapy. J Comp Neurol (2005) 1.03
Light-induced c-fos in melanopsin retinal ganglion cells of young and aged rodless/coneless (rd/rd cl) mice. Eur J Neurosci (2003) 1.01
Partial preservation of rod and cone ERG function following subretinal injection of ARPE-19 cells in RCS rats. Vision Res (2005) 1.01
Zeb1 represses Mitf and regulates pigment synthesis, cell proliferation, and epithelial morphology. Invest Ophthalmol Vis Sci (2009) 1.00
Autologous transplantation of retinal pigment epithelium-Bruch's membrane complex for hemorrhagic age-related macular degeneration. Invest Ophthalmol Vis Sci (2008) 0.96
Non cell-autonomous reprogramming of adult ocular progenitors: generation of pluripotent stem cells without exogenous transcription factors. Stem Cells (2009) 0.96
Retinal pigment epithelial cells secrete neurotrophic factors and synthesize dopamine: possible contribution to therapeutic effects of RPE cell transplantation in Parkinson's disease. J Transl Med (2009) 0.96
Photoreceptor rescue in the RCS rat without pigment epithelium transplantation. Curr Eye Res (1990) 0.94
Pigment epithelium derived factor (PEDF) is neuroprotective in two in vitro models of Parkinson's disease. Neurosci Lett (2009) 0.94
Schwann cell grafting into the retina of the dystrophic RCS rat limits functional deterioration. Royal College of Surgeons. Invest Ophthalmol Vis Sci (2000) 0.93
A comparison of macular translocation with patch graft in neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci (2008) 0.91
Fos expression in the retina of rd/rd mice during the light/dark cycle. Neurosci Lett (1997) 0.90
Rod outer segment maintenance is enhanced in the presence of bFGF, CNTF and GDNF. Exp Eye Res (1998) 0.88
Xenotransplantation of retinal pigment epithelial cells into RCS rats. Jpn J Ophthalmol (2002) 0.87
Triple immune suppression increases short-term survival of porcine fetal retinal pigment epithelium xenografts. Invest Ophthalmol Vis Sci (2003) 0.85
Therapeutic effect of microencapsulated porcine retinal pigmented epithelial cells transplantation on rat model of Parkinson's disease. Neurosci Bull (2007) 0.84
Morphological integration and functional assessment of transplanted neural progenitor cells in healthy and acute ischemic rat eyes. Exp Eye Res (2005) 0.84
Evidence of retinal function using microperimetry following autologous retinal pigment epithelium-choroid graft in macular dystrophy. Invest Ophthalmol Vis Sci (2008) 0.83
Cellular response in rabbit eyes after human fetal RPE cell transplantation. Graefes Arch Clin Exp Ophthalmol (1999) 0.83
Preservation of photoreceptors in dystrophic RCS rats following allo- and xenotransplantation of IPE cells. Graefes Arch Clin Exp Ophthalmol (2008) 0.81
Preservation of visual cortical function following retinal pigment epithelium transplantation in the RCS rat using optical imaging techniques. Eur J Neurosci (2007) 0.81
Tissue culture of retinal pigment epithelium following isolation with a gelatin matrix technique. Exp Eye Res (1997) 0.80
Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med (2008) 17.19
A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci U S A (2005) 13.44
The burden of diabetes mellitus among US youth: prevalence estimates from the SEARCH for Diabetes in Youth Study. Pediatrics (2006) 7.19
A role for local inflammation in the formation of drusen in the aging eye. Am J Ophthalmol (2002) 5.57
The effect of continuous glucose monitoring in well-controlled type 1 diabetes. Diabetes Care (2009) 4.93
The pivotal role of the complement system in aging and age-related macular degeneration: hypothesis re-visited. Prog Retin Eye Res (2009) 3.40
Interim results from the international trial of Second Sight's visual prosthesis. Ophthalmology (2012) 3.35
Bevacizumab for neovascular age related macular degeneration (ABC Trial): multicentre randomised double masked study. BMJ (2010) 3.12
Age-related macular degeneration--emerging pathogenetic and therapeutic concepts. Ann Med (2006) 2.99
Factors predictive of use and of benefit from continuous glucose monitoring in type 1 diabetes. Diabetes Care (2009) 2.85
Derivation of functional retinal pigmented epithelium from induced pluripotent stem cells. Stem Cells (2009) 2.70
Melanopsin contributions to irradiance coding in the thalamo-cortical visual system. PLoS Biol (2010) 2.56
Parity, mode of delivery, and pelvic floor disorders. Obstet Gynecol (2006) 2.45
Characterization of beta amyloid assemblies in drusen: the deposits associated with aging and age-related macular degeneration. Exp Eye Res (2004) 2.32
The relative contribution of prepregnancy overweight and obesity, gestational weight gain, and IADPSG-defined gestational diabetes mellitus to fetal overgrowth. Diabetes Care (2012) 2.31
Etiological approach to characterization of diabetes type: the SEARCH for Diabetes in Youth Study. Diabetes Care (2011) 2.15
Prevalence of overweight and obesity in youth with diabetes in USA: the SEARCH for Diabetes in Youth study. Pediatr Diabetes (2009) 2.15
Projections of type 1 and type 2 diabetes burden in the U.S. population aged <20 years through 2050: dynamic modeling of incidence, mortality, and population growth. Diabetes Care (2012) 2.12
Epidemiology of prolapse and incontinence questionnaire: validation of a new epidemiologic survey. Int Urogynecol J Pelvic Floor Dysfunct (2005) 2.04
Elucidating the phenomenon of HESC-derived RPE: anatomy of cell genesis, expansion and retinal transplantation. Exp Neurol (2008) 2.03
Epidemiology of type 1 diabetes. Endocrinol Metab Clin North Am (2010) 2.02
Prevalence of diabetes in U.S. youth in 2009: the SEARCH for diabetes in youth study. Diabetes Care (2013) 2.01
Use of spectral-domain optical coherence tomography to differentiate acquired retinoschisis from retinal detachment in difficult cases. Retina (2012) 1.99
Diabetes in African American youth: prevalence, incidence, and clinical characteristics: the SEARCH for Diabetes in Youth Study. Diabetes Care (2009) 1.91
Diabetes in non-Hispanic white youth: prevalence, incidence, and clinical characteristics: the SEARCH for Diabetes in Youth Study. Diabetes Care (2009) 1.80
Transcription factor 7-like 2 (TCF7L2) is associated with gestational diabetes mellitus and interacts with adiposity to alter insulin secretion in Mexican Americans. Diabetes (2007) 1.79
Drusen-associated degeneration in the retina. Invest Ophthalmol Vis Sci (2003) 1.75
Memory in induced pluripotent stem cells: reprogrammed human retinal-pigmented epithelial cells show tendency for spontaneous redifferentiation. Stem Cells (2010) 1.71
Participation in pediatric epidemiologic research: the SEARCH for Diabetes in Youth Study experience. Contemp Clin Trials (2008) 1.69
Construction of a multisite DataLink using electronic health records for the identification, surveillance, prevention, and management of diabetes mellitus: the SUPREME-DM project. Prev Chronic Dis (2012) 1.66
RPE transplantation and its role in retinal disease. Prog Retin Eye Res (2007) 1.63
Prevalence of tobacco use and association between cardiometabolic risk factors and cigarette smoking in youth with type 1 or type 2 diabetes mellitus. J Pediatr (2010) 1.63
Complement factor H deficiency in aged mice causes retinal abnormalities and visual dysfunction. Proc Natl Acad Sci U S A (2007) 1.62
Stem cells in retinal regeneration: past, present and future. Development (2013) 1.59
Correlates of dietary intake in youth with diabetes: results from the SEARCH for diabetes in youth study. J Nutr Educ Behav (2011) 1.56
Anti-amyloid therapy protects against retinal pigmented epithelium damage and vision loss in a model of age-related macular degeneration. Proc Natl Acad Sci U S A (2011) 1.56
The many faces of diabetes in American youth: type 1 and type 2 diabetes in five race and ethnic populations: the SEARCH for Diabetes in Youth Study. Diabetes Care (2009) 1.54
Synaptic pathology, altered gene expression, and degeneration in photoreceptors impacted by drusen. Invest Ophthalmol Vis Sci (2005) 1.53
Type 1 and Type 2 diabetes in Asian and Pacific Islander U.S. youth: the SEARCH for Diabetes in Youth Study. Diabetes Care (2009) 1.52
Development of human embryonic stem cell therapies for age-related macular degeneration. Trends Neurosci (2013) 1.51
MicroRNA profiling reveals two distinct p53-related human pluripotent stem cell states. Cell Stem Cell (2010) 1.49
Trends in the prevalence of ketoacidosis at diabetes diagnosis: the SEARCH for diabetes in youth study. Pediatrics (2014) 1.49
The effect of hypercapnia on the neural and hemodynamic responses to somatosensory stimulation. Neuroimage (2005) 1.47
Systems-level analysis of age-related macular degeneration reveals global biomarkers and phenotype-specific functional networks. Genome Med (2012) 1.46
Autologous transplantation of the retinal pigment epithelium and choroid in the treatment of neovascular age-related macular degeneration. Ophthalmology (2007) 1.44
Association between the dietary approaches to hypertension diet and hypertension in youth with diabetes mellitus. Hypertension (2008) 1.43
Transition from pediatric to adult care for youth diagnosed with type 1 diabetes in adolescence. Pediatrics (2013) 1.38
Molecular characterization and functional analysis of phagocytosis by human embryonic stem cell-derived RPE cells using a novel human retinal assay. Mol Vis (2009) 1.35
Health-related quality of life of children and adolescents with type 1 or type 2 diabetes mellitus: SEARCH for Diabetes in Youth Study. Arch Pediatr Adolesc Med (2008) 1.35
The Detection of Motion by Blind Subjects With the Epiretinal 60-Electrode (Argus II) Retinal Prosthesis. JAMA Ophthalmol (2013) 1.32
Association between maternal diabetes in utero and age at offspring's diagnosis of type 2 diabetes. Diabetes Care (2008) 1.31
Chondroitin sulfate proteoglycans and microglia prevent migration and integration of grafted Müller stem cells into degenerating retina. Stem Cells (2008) 1.31
Body weight and height data in electronic medical records of children. Int J Pediatr Obes (2010) 1.29
Pluripotent human stem cells for the treatment of retinal disease. J Cell Physiol (2012) 1.29
Rapid and efficient directed differentiation of human pluripotent stem cells into retinal pigmented epithelium. Stem Cells Transl Med (2013) 1.27
Differentiation of human pluripotent stem cells to retinal pigmented epithelium in defined conditions using purified extracellular matrix proteins. J Tissue Eng Regen Med (2012) 1.27
Prevalence, characteristics and clinical diagnosis of maturity onset diabetes of the young due to mutations in HNF1A, HNF4A, and glucokinase: results from the SEARCH for Diabetes in Youth. J Clin Endocrinol Metab (2013) 1.26
Quality-of-life measures in children and adults with type 1 diabetes: Juvenile Diabetes Research Foundation Continuous Glucose Monitoring randomized trial. Diabetes Care (2010) 1.26
A versatile approach to high-throughput microarrays using thiol-ene chemistry. Nat Chem (2009) 1.24
Roles of integrins in human induced pluripotent stem cell growth on Matrigel and vitronectin. Stem Cells Dev (2010) 1.20
Clinical outcomes of pregnancies complicated by mild gestational diabetes mellitus differ by combinations of abnormal oral glucose tolerance test values. Diabetes Care (2010) 1.18
Racial and ethnic disparities in the trends in primary cesarean delivery based on indications. Am J Obstet Gynecol (2009) 1.18
Soluble and mature amyloid fibrils in drusen deposits. Invest Ophthalmol Vis Sci (2009) 1.18
Association of type 1 diabetes with month of birth among U.S. youth: The SEARCH for Diabetes in Youth Study. Diabetes Care (2009) 1.17
Dopamine neurones form a discrete plexus with melanopsin cells in normal and degenerating retina. Exp Neurol (2007) 1.17
Factors predictive of severe hypoglycemia in type 1 diabetes: analysis from the Juvenile Diabetes Research Foundation continuous glucose monitoring randomized control trial dataset. Diabetes Care (2011) 1.17
Evidence of interaction between PPARG2 and HNF4A contributing to variation in insulin sensitivity in Mexican Americans. Diabetes (2007) 1.14
Synthetic surfaces for human embryonic stem cell culture. J Biotechnol (2010) 1.13
Adherence to guidelines for youths with diabetes mellitus. Pediatrics (2011) 1.13
Embryonic stem cells and retinal repair. Mech Dev (2007) 1.13
Long-term evaluation of retinal function in Prph2Rd2/Rd2 mice following AAV-mediated gene replacement therapy. J Gene Med (2003) 1.12
Trends in diabetes incidence among 7 million insured adults, 2006-2011: the SUPREME-DM project. Am J Epidemiol (2014) 1.11
MUC1* mediates the growth of human pluripotent stem cells. PLoS One (2008) 1.10